Skip to content

UNITY DX Cornea Study

UNITY DX Cornea Precision and Agreement Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07768735
Enrollment
110
Registered
2026-08-17
Start date
2026-09-01
Completion date
2026-12-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tomography

Keywords

Corneal surgery, Refractive surgery, Biometric parameters, Keratoconus, Dry eye, Laser vision correction

Brief summary

The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of corneal and epithelial thickness maps will be evaluated.

Detailed description

The study population will consist of male and female adult subjects with normal corneas (approximately 30 subjects), keratoconus (approximately 20 subjects), prior corneal laser vision correction (approximately 20 subjects), current and habitual contact lens wear (approximately 20 subjects), and dry eye (approximately 20 subjects). In this single visit study, measurements will be taken by 3 different operators using their own set of devices (configuration), UNITY DX and ANTERION. Each subject's participation is expected to last approximately 3 hours with a planned duration of exposure generally not longer than 10 minutes per device. Only one eye (designated as the study eye) will be enrolled per subject.

Interventions

DEVICEUNITY DX

Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

DEVICEANTERION

Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Key Inclusion Criteria: * Able to understand and sign an Institutional Review Board approved informed consent form. * Willing and able to attend all scheduled study visits as required per protocol. * Identified by the investigator as having normal corneas or abnormal corneas per protocol-specified criteria. * Other protocol-specified inclusion criteria may apply. Key

Exclusion criteria

* Unable to fixate due to nystagmus or other eye movement abnormality, such as significant strabismus. * Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study. * Active ocular infection or inflammation. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Mean corneal thicknessDay 1Corneal thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility.
Mean epithelial thicknessDay 1Epithelial thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility.

Countries

United States

Contacts

CONTACTAlcon Call Center
alcon.medinfo@alcon.com1-888-451-3937
STUDY_DIRECTORClinical Trial Lead, Surgical

Alcon Research, LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026